M. Gail Murphy

1.8k citations

43 papers · 1.3k indexed · h-index 21

Impact in

Endocrine and Autonomic Systems top 5%
- Regulation of Appetite and Obesity
Psychiatry and Mental health top 5%
- Migraine and Headache Studies

Papers in

Psychiatry and Mental health 12
- Migraine and Headache Studies 8
Endocrine and Autonomic Systems 5
- Circadian rhythm and melatonin 4

Co-authors: K. Cerchio Keith Gottesdiener B. J. Gertz John Palcza Anup Majumdar S. Aubrey Stoch Mark A. Bach R. R. Recker
Journals: The Journal of Clinical Pharmacology (6 papers)Clinical Pharmacology & Therapeutics (4 papers)British Journal of Clinical Pharmacology (4 papers)The Journal of Clinical Endocrinology & Metabolism (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)
Partner nations: United States Belgium United Kingdom

In The Last Decade

M. Gail Murphy

43 papers receiving 1.2k citations

Peers

Countries citing papers authored by M. Gail Murphy

Since Specialization

Citations

This map shows the geographic impact of M. Gail Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Gail Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Gail Murphy more than expected).

Fields of papers citing papers by M. Gail Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Gail Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Gail Murphy. The network helps show where M. Gail Murphy may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Gail Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Gail Murphy Line = papers co-authored together M. Gail Murphy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Randomized, Placebo-Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina Clinical Pharmacology & Therapeutics ·Bernard Chaitman, Andrew P. Ho, Baptiste Voillequin, Jason F. Rowe, John Palcza, Tine Laethem, Ingeborg Heirman, Deborah Panebianco, Ж. Д. Кобалава, S. Yu. Martsevich, Simon Tabuni, Neville Bittar, Steven G. Chrysant, Tony W. Ho, J Chodakewitz, M. Gail Murphy, Rebecca Blanchard	2012	48
2	Effect of Telcagepant on Spontaneous Ischemia in Cardiovascular Patients in a Randomized Study Headache The Journal of Head and Face Pain ·Cheng Siyi, Rebecca Blanchard, M. Gail Murphy, John Palcza, Carlos Basso Luiz, Dionísio Eduardo Gonçalves Fernandes, William Smith, Richard A. Preston, Jeffrey Chodakewitz, Mitchell W. Krucoff	2011	16
3	The Dose Proportionality of Telcagepant after Administration of Single Oral and Intravenous Doses in Healthy Adult Subjects PubMed ·Tae Hyung Han, Rebecca Blanchard, John Palcza, Kostiushko Av, Cynthia Miller‐Stein, María J. Gutiérrez, Deborah Panebianco, BakerThomas, Christopher Lines, M. Gail Murphy	2010	9
4	THE CALCITONIN GENE-RELATED PEPTIDE RECEPTOR ANTAGONIST TELCAGEPANT DOES NOT REDUCE EXERCISE TOLERANCE IN PATIENTS WITH EXERCISE INDUCED MYOCARDIAL ISCHEMIA Journal of the American College of Cardiology ·Bernard Chaitman, Andrew P. Ho, Cheng Siyi, Janice Rowe, John Palcza, Tine Laethem, Ingeborg Heirman, Deborah Panebianco, Qian-Ru Qi, S. Yu. Martsevich, Almena Free, Neville Bittar, Steven G. Chrysant, Tony W. Ho, Jeffrey Chodakewitz, M. Gail Murphy, Rebecca Blanchard	2010	4
5	Acute Alertness-Promoting Effects of a Novel Histamine Subtype-3 Receptor Inverse Agonist in Healthy Sleep-Deprived Male Volunteers Clinical Pharmacology & Therapeutics ·Raffaele Iannone, John Palcza, John J. Renger, Nicole Calder, K. Cerchio, Keith Gottesdiener, Richard Hargreaves, Derk‐Jan Dijk, Tim P. Salmon, M. Gail Murphy	2010	26
6	Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant Cancer Chemotherapy and Pharmacology ·S. Aubrey Stoch, Cynthia Gargano, J L Valentine, Matthew P. Braun, M. Gail Murphy, M. Zellner, Anup Majumdar, Edward Pequignot, Keith Gottesdiener, Kevin J. Petty, Deborah Panebianco, Dennis Dean, Walter K. Kraft, Howard Greenberg	2010	13
7	The potent calcitonin gene‐related peptide receptor antagonist, telcagepant, does not affect nitroglycerin‐induced vasodilation in healthy men British Journal of Clinical Pharmacology ·Bart Van der Schueren, Rebecca Blanchard, M. Gail Murphy, John Palcza, Inge De Lepeleire, Anne Van Hecken, Marleen Depré, Jan de Hoon	2010	30
8	Lack of significant pharmacodynamic interaction between telcagepant 600 mg and sumatriptan 100 mg Cephalalgia ·Jan de Hoon, Caitlin S. MacLeod, John Palcza, Baptiste Voillequin, Marleen Depré, Inge De Lepeleire, Tae Hyung Han, Tuteja Shikha, William Smith, Gertrude Noonan, Rebecca Blanchard, J Chodakewitz, M. Gail Murphy	2009	5
9	Inhibition of capsaicin‐induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK‐0974) British Journal of Clinical Pharmacology ·Simon Sinclair, Stefanie A. Kane, Bart Van der Schueren, Alan Xiao, Kelbe David, 真理稲葉, Inge De Lepeleire, Yang Xu, Lisa Hickey, William S. Denney, Chi‐Chung Li, John Palcza, Floris Vanmolkot, Marleen Depré, Anne Van Hecken, M. Gail Murphy, Tony W. Ho, Andrew Hibling	2009	70
10	Lack of Effect of Aprepitant or Its Prodrug Fosaprepitant on QTc Intervals in Healthy Subjects Anesthesia & Analgesia ·Thomas Marbury, Bo Jin, Deborah Panebianco, M. Gail Murphy, Hong Sun, Judith K. Evans, Tae Hyung Han, M.L. Constanzer, Muhammad Zaid Ramadhan, Y.Gómez Kosky	2009	13
11	Tolerability, pharmacokinetics and night‐time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects British Journal of Clinical Pharmacology ·Julia Boyle, Philippe Danjou, Robert Alexander, Nicole Calder, Cynthia Gargano, Nancy Agrawal, I. Fu, Jacqueline B. McCrea, M. Gail Murphy	2008	25
12	MK-0974, a novel oral CGRP antagonist, exhibits similar pharmacokinetics during and between migraine attacks Headache The Journal of Head and Face Pain ·Simon Sinclair, Zheng Jia-bin, Inge De Lepeleire, Stefanie A. Kane, Rebecca Blanchard, Kelbe David, Yanping Xu, Laurence E. Krap, John Palcza, Jan de Hoon, M. Gail Murphy	2007	7
13	MK-0974, an oral CGRP antagonist, inhibits capsaicin-induced vasodilation in the human skin Basic & Clinical Pharmacology & Toxicology ·Bart Van der Schueren, Jan de Hoon, MohamedS Abdullah, Kimberly D. Kennel, Kelbe David, Yingling Xu, Lisa Hickey, John Palcza, Inge De Lepeleire, Floris Vanmolkot, Anne Van Hecken, Marleen Depré, M. Gail Murphy, Simon Sinclair	2007	2
14	Tolerability of Fosaprepitant and Bioequivalency to Aprepitant in Healthy Subjects The Journal of Clinical Pharmacology ·Kenneth C. Lasseter, Yang Jin‐rui, Bo Jin, YK Yusuf, M.L. Constanzer, Muhammad Zaid Ramadhan, Tae Hyung Han, Anup Majumdar, Judith K. Evans, M. Gail Murphy	2007	88
15	METABOLISM AND DISPOSITION OF A POTENT AND SELECTIVE GABA-Aα2/3 RECEPTOR AGONIST IN HEALTHY MALE VOLUNTEERS Drug Metabolism and Disposition ·P.C. Conor, S. Vickers, Donghui Cui, Raju Subramanian, Byron H. Arison, Nancy Agrawal, Brynn Knowlton, S Montri, M. Gail Murphy, Kenneth C. Lasseter, Richard C. Simpson, José M. Vega, A. David Rodrigues	2006	9
16	Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients Cancer Chemotherapy and Pharmacology ·Peter Nygren, Kenneth R. Hande, Kevin J. Petty, M. Zellner, Kristien Van Dyck, Anup Majumdar, Tuteja Shikha, Marina De Smet, Tuli Ahmed, M. Gail Murphy, Keith Gottesdiener, Véronique Cocquyt, Simon Van Belle	2005	56
17	Pharmacokinetics of Famotidine in Infants Clinical Pharmacokinetics ·Larissa Wenning, M. Gail Murphy, Laura P. James, Jeffrey L. Blumer, James D. Marshall, Marco Armanno, Ann Scheimann, Deborah Panebianco, L. Zhong, ISOBEL MARGUERITE SUSON NGO, K. C. Yeh, Gregory L. Kearns	2005	9
18	Effect of Alendronate and MK-677 (a Growth Hormone Secretagogue), Individually and in Combination, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic Women¹ The Journal of Clinical Endocrinology & Metabolism ·M. Gail Murphy, (unknown), Michael R. McClung, Thomas J. Schnitzer, K. Cerchio, Jennie Connor, David Krupa, B. J. Gertz	2001	67
19	Human Pharmacokinetics and Tolerability of L‐365,260, a Novel Cholecystokinin‐B Antagonist The Journal of Clinical Pharmacology ·Kenneth Grasing, M. Gail Murphy, I. Llorach Gaspar, Mary E. Swigar, Debra Freedholm, Laura Clarke, Carolina Chalarca, Owen M. Wolkowitz, Herbert Weingartner, Karen Putnam, James R. Seibold	1996	7
20	The gastrin-receptor antagonist L-365,260 inhibits stimulated acid secretion in humans Clinical Pharmacology & Therapeutics ·M. Gail Murphy, PROF MARWAN MAS, Thomas O. Kovacs, Howard Mertz, shuo liu, Sumiko Shingo, I. Llorach Gaspar, Barry J. Gertz, John H. Walsh	1993	27

About M. Gail Murphy

M. Gail Murphy is a scholar working on Psychiatry and Mental health, Endocrine and Autonomic Systems, Anesthesiology and Pain Medicine, Endocrinology, Diabetes and Metabolism and Sensory Systems, having authored 43 papers that have together received 1.3k indexed citations. Recurring topics across this work include Migraine and Headache Studies (8 papers), Nausea and vomiting management (7 papers), Anesthesia and Pain Management (5 papers), Growth Hormone and Insulin-like Growth Factors (5 papers), Pharmaceutical studies and practices (5 papers), Neuropeptides and Animal Physiology (4 papers), Heart Rate Variability and Autonomic Control (4 papers) and Circadian rhythm and melatonin (4 papers). The work is most often cited by research in Endocrine and Autonomic Systems (198 citations), Psychiatry and Mental health (259 citations), Anesthesiology and Pain Medicine (85 citations), Physiology (350 citations) and Cellular and Molecular Neuroscience (222 citations). M. Gail Murphy has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include K. Cerchio, Keith Gottesdiener, B. J. Gertz, John Palcza, Anup Majumdar, S. Aubrey Stoch, Mark A. Bach, R. R. Recker, Mei Wu and Tae Hyung Han. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology, The Journal of Clinical Endocrinology & Metabolism and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact